David Sherr

Prof Dr David Sherr is a founder of Hercules and has published over 100 peer-reviewed articles, many of which relate to AhR in cancer. David is Director of the Immunology Training Program at Boston University School Of Medicine and Director of the Boston University Superfund Research Program.